Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Alibaba Health Information Technology EV-to-EBITDA?
Alibaba Health Information TechnologyALBHF 51 EV-to-EBITDA is 17.31 as of Aug. 08, 2026, which is 29% below its 10-year median of 24.51. GuruFocus rates ALBHF with a GF Scoreâ„¢ of 51/100 and a GF Valueâ„¢ of $0.66 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 510 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks worse than 73.14% on this metric.
ALBHF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -5218.55 Med: 24.51 Max: 4318.32
Current: 17.88
During the past 13 years, the highest EV-to-EBITDA of Alibaba Health Information Technology was 4318.32. The lowest was -5218.55. And the median was 24.51.
ALBHF's EV-to-EBITDA is ranked worse than 73.14% of 510
companies
in the Healthcare Providers & Services industry
Industry Median: 10.92
vs ALBHF: 17.88
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Alibaba Health Information Technology (OTCPK:ALBHF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Alibaba Health Information Technology's PE Ratio (TTM) for today is calculated as:
Alibaba Health Information Technology's share price for today is $0.4455.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alibaba Health Information Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.017.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology EV-to-EBITDA Chart
Alibaba Health Information Technology EV-to-EBITDA Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's EV-to-EBITDA falls into.
Alibaba Health Information Technology's current Enterprise Value is $5,731 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alibaba Health Information Technology's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $331 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology (ALBHF) has a EV-to-EBITDA of 17.31 as of Aug. 08, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Alibaba Health Information Technology. This is 29% below median its historical median of 24.51. According to the industry distribution chart, Alibaba Health Information Technology ranks #373 out of 510 companies in the Healthcare Providers & Services industry, placing it in the top 73.1%.
Is Alibaba Health Information Technology's EV-to-EBITDA too high?
Alibaba Health Information Technology's current EV-to-EBITDA of 17.31 is 29% below median its 10-year median of 24.51. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.92. Alibaba Health Information Technology's value of 17.31 is 58.5% above this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #373 out of 510 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Alibaba Health Information Technology has a GF Scoreâ„¢ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's EV-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #373 out of 510 companies for EV-to-EBITDA. This places Alibaba Health Information Technology in the lower half of its industry. The industry median EV-to-EBITDA is 10.92. Alibaba Health Information Technology's value of 17.31 is 58.5% above this benchmark. While the company's 10-year median is 24.51 vs. the industry median of 10.92, Alibaba Health Information Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.92, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current EV-to-EBITDA of 17.31 is 58.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Alibaba Health Information Technology. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current EV-to-EBITDA is 17.31, which is 29% below median its own 10-year median of 24.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.66, compared to a current price of $0.45 — trading 32.5% below its estimated fair value. The current EV-to-EBITDA is 17.31, which is 29% below median its 10-year median of 24.51 and 58.5% above the Healthcare Providers & Services industry median of 10.92. Alibaba Health Information Technology's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current EV-to-EBITDA is 17.31 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of $0.45 is trading 32.5% below its estimated GF Value™ of $0.66.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for ALBHF:
EV-to-EBITDA: 17.31 (29% below median its 10-year median of 24.51)
GF Value™: $0.66 vs. price of $0.45 (32.5% below fair value)
Industry Position: 58.5% above the Healthcare Providers & Services median (#373 of 510)
No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
51GF Score
Get the complete analysis for ALBHF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALBHF has been successfully added to your 
